Conference Details - Faculty

View all Conferences

Continuing Education Information

Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity is approved for AMA PRA Category 1 Credit

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.

Current Trends in Leukemia, Lymphoma, and Myeloma

The Fairmont Washington, D.C.
Washington, DC
January 31, 2009

Program Director

Bruce D. Cheson, MD, FACP
Professor of Medicine
Head of Hematology
Director, Hematology Research
Georgetown University Hospital
Lombardi Comprehensive Cancer Center
Washington, DC

Faculty

Rebecca Elstrom, MD
Assistant Professor
Division of Hematology and Medical Oncology
Weill Cornell Medical College
New York, NY

Terry Gernsheimer, MD
Associate Professor of Medicine
Division of Hematology
University of Washington School of Medicine
Seattle, WA

Sagar Lonial, MD
Associate Professor
Emory University School of Medicine
Director, Translational Research
B-Cell Malignancy Program
Emory Winship Cancer Institute
Atlanta, GA

Richard T. Silver, MD
Director, Leukemia and Myeloproliferative Center
NewYork-Presbyterian Hospital
Professor of Medicine
Weill Cornell Medical College
New York, NY

B. Douglas Smith, MD
Associate Professor of Medicine, Hematology, and Oncology
Division of Hematology
Department of Medicine
Mayo Clinic
Rochester, MN

David Steensma, MD
Associate Professor of Medicine, Hematology, and Oncology
Division of Hematology
Department of Medicine
Mayo Clinic
Rochester, MN

Andrew D. Zelenetz, MD, PhD
Chief, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, NY

Educational Grants

An educational grant for this activity was provided by:


  1. GlaxoSmithKline
  2. Celgene Corporation
  3. Genentech BioOncology/
    Biogen Idec
  4. Millennium Pharmaceuticals